Skip to content
10-Q

Quarterly Report

ESCALON MEDICAL CORP ESMC

0000862668-23-000027

← back to feed
Filed
Nov 17, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2024 · Nov 16, 2023 7.42M sh
Cash And Equivalents Q1 2024 · Sep 30, 2023 $744.83K
Cash And Equivalents Q1 2024 · Jun 30, 2023 $889.67K
Cash And Equivalents Q1 2024 · Sep 30, 2022 $275.15K
Cash And Equivalents Q1 2024 · Jun 30, 2022 $593.87K
Current Liabilities Q1 2024 · Sep 30, 2023 $2.6M
Current Liabilities Q1 2024 · Jun 30, 2023 $2.85M
Total Liabilities Q1 2024 · Sep 30, 2023 $3.01M
Total Liabilities Q1 2024 · Jun 30, 2023 $3.37M
Current Assets Q1 2024 · Sep 30, 2023 $4.33M
Current Assets Q1 2024 · Jun 30, 2023 $4.64M
Total Assets Q1 2024 · Sep 30, 2023 $4.93M
Total Assets Q1 2024 · Jun 30, 2023 $5.31M
Stockholders Equity Q1 2024 · Mar 31, 2023 $1.91M
Stockholders Equity Q1 2024 · Jun 30, 2022 $1.48M
Stockholders Equity Q1 2024 · Mar 31, 2022 $1.16M
Net Income Q1 2024 · Mar 31, 2023 −$21.2K
Net Income Q1 2024 · Sep 30, 2022 −$320.72K
Net Income Q1 2024 · Mar 31, 2022 −$320.72K
Shares Diluted Q1 2024 · Sep 30, 2022 7.42M sh
Capex Q1 2024 · Sep 30, 2022 $0
Operating Cash Flow Q1 2024 · Sep 30, 2022 −$310.38K
Eps Diluted Q1 2024 · Sep 30, 2022 −$0.05
Eps Basic Q1 2024 · Sep 30, 2022 −$0.05
Sga Expense Q1 2024 · Sep 30, 2022 $1.11M
Rd Expense Q1 2024 · Sep 30, 2022 $264.24K
Operating Income Q1 2024 · Sep 30, 2022 −$315.9K
Cost Of Revenue Q1 2024 · Sep 30, 2022 $1.55M